TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35396860

Group type: EXPERIMENTAL
Intervention: Sympatex glove underneath a cotton glove (SYM/COT)
Number of subjects: 199

Group type: COMPARATOR
Intervention: Cotton glove (COT)
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: Both SYM/COT and COT
Number of subjects: 199
Study: 32653397

Group type: EXPERIMENTAL
Intervention: Satisfaction with antenatal care
Number of subjects: 287

Group type: EXPERIMENTAL
Intervention: Understanding the information provided by health professionals during labor and delivery
Number of subjects: 287

Group type: EXPERIMENTAL
Intervention: Not having reported disrespect and abuse
Number of subjects: 287

Group type: EXPERIMENTAL
Intervention: Having had the baby put to the breast within the first hour of life
Number of subjects: 287
Study: 35213517

Group type: EXPERIMENTAL
Intervention: 1 mg E2/100 mg P4
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: 0.5 mg E2/100 mg P4
Number of subjects: 157

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 157
Study: 32510250

Group type: EXPERIMENTAL
Intervention: Endovascular carotid baroreflex amplification device
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham-controlled renal nerve denervation
Number of subjects: 0
Study: 33420480

Group type: EXPERIMENTAL
Intervention: OCPs (0.15 mg levonorgestrel + 0.30 μg ethinyl estradiol)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: OCPs
Number of subjects: 26
Study: 32678321

Group type: EXPERIMENTAL
Intervention: Sleep duration ≥8 hours per day
Number of subjects: 14485

Group type: EXPERIMENTAL
Intervention: Poor sleep quality
Number of subjects: 14485

Group type: EXPERIMENTAL
Intervention: Sleep duration ≥8 hours and/or poor sleep quality
Number of subjects: 14485
Study: 36346544

Group type: EXPERIMENTAL
Intervention: Remimazolam
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Remimazolam plus dexmedetomidine
Number of subjects: 90

Group type: COMPARATOR
Intervention: Propofol control
Number of subjects: 90

Group type: COMPARATOR
Intervention: Remimazolam, Remimazolam plus dexmedetomidine, Propofol control
Number of subjects: 90
Study: 33526623

Group type: EXPERIMENTAL
Intervention: MTX + pred (methotrexate with prednisone)
Number of subjects: 0

Group type: COMPARATOR
Intervention: MTX + PBO (methotrexate with placebo)
Number of subjects: 0
Study: 36258179

Group type: EXPERIMENTAL
Intervention: group version of the Lifestyle-integrated Functional Exercise program (gLiFE)
Number of subjects: 237

Group type: COMPARATOR
Intervention: individually delivered version (LiFE)
Number of subjects: 237
Study: 33676071

Group type: EXPERIMENTAL
Intervention: SAFE Face-to-face intervention
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: SAFE Computer-adapted intervention
Number of subjects: 90

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 90
Study: 34962164

Group type: EXPERIMENTAL
Intervention: Closed-loop control system (CLC)
Number of subjects: 35
Study: 32799056

Group type: EXPERIMENTAL
Intervention: Efficacy messages
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Threat/efficacy messages
Number of subjects: 320

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 320
Study: 34740588

Group type: EXPERIMENTAL
Intervention: PROMIS pediatric measures
Number of subjects: 266
Study: 33587132

Group type: EXPERIMENTAL
Intervention: Multimodal coordinated care intervention including ≥3 APC clinic visits, ≥3 CHW home visits, Chronic Disease Self‐Management Program workshops, additional telephone visits, protocol‐driven risk factor management, culturally and linguistically tailored education materials, and self‐management tools.
Number of subjects: 487

Group type: COMPARATOR
Intervention: Usual care, which varied by site but frequently included a free BP monitor, self‐management tools, and linguistically tailored information materials.
Number of subjects: 487
Study: 32992020

Group type: EXPERIMENTAL
Intervention: Mindfulness intervention (Breathing and Attention Training, BAT) combined with transcranial direct current stimulation (tDCS)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Sham BAT combined with Sham tDCS
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Real BAT combined with Sham tDCS
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sham BAT combined with Real tDCS
Number of subjects: 0
Study: 33225772

Group type: EXPERIMENTAL
Intervention: Phototherapy plus UDCA (10 mg/kg/day)
Number of subjects: 220

Group type: COMPARATOR
Intervention: Phototherapy (Control group)
Number of subjects: 220
Study: 32507929

Group type: EXPERIMENTAL
Intervention: Rapid response (RR)
Number of subjects: 210

Group type: EXPERIMENTAL
Intervention: Baseline ED pathology
Number of subjects: 210
Study: 32240122

Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 126

Group type: COMPARATOR
Intervention: Sitagliptin
Number of subjects: 126
Study: 36026684

Group type: EXPERIMENTAL
Intervention: Preprocedural MRI scan of the heart and 3D printing of left atrium and pulmonary veins with cryoablation
Number of subjects: 100

Group type: COMPARATOR
Intervention: Standard cryoablation without imaging
Number of subjects: 100
Study: 32875451

Group type: EXPERIMENTAL
Intervention: Pomegranate peel supplementation via water (0.3 g L‐1)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Pomegranate peel supplementation via diet (1 g PP powder/kg diet)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Pomegranate peel supplementation via diet (2 g PP powder/kg diet)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Control group (basal diet)
Number of subjects: 240

Group type: COMPARATOR
Intervention: Positive control (Hg exposure, basal diet)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Hg + Pomegranate peel supplementation via water (0.3 g L‐1)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Hg + Pomegranate peel supplementation via diet (1 g PP powder/kg diet)
Number of subjects: 240

Group type: EXPERIMENTAL
Intervention: Hg + Pomegranate peel supplementation via diet (2 g PP powder/kg diet)
Number of subjects: 240
Study: 34657655

Group type: EXPERIMENTAL
Intervention: Rezum
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: UroLift
Number of subjects: 0
Study: 32029429

Group type: EXPERIMENTAL
Intervention: Cervical injection of 99m Tc at the 3 and 9 o'clock positions of the uterine cervix
Number of subjects: 81

Group type: COMPARATOR
Intervention: Endometrial injection of 99m Tc into the fundal endometrium using a transcervical catheter
Number of subjects: 81
Study: 33506983

Group type: EXPERIMENTAL
Intervention: Left lateral decubitus (LL) position
Number of subjects: 212

Group type: COMPARATOR
Intervention: Prone position
Number of subjects: 212
Study: 35253570

Group type: EXPERIMENTAL
Intervention: Serum neurofilament light (NFL) sampled 48/72-hours post-arrest
Number of subjects: 457

Group type: EXPERIMENTAL
Intervention: Cerebral Performance Category (CPC)
Number of subjects: 457

Group type: EXPERIMENTAL
Intervention: Mini-Mental State Examination (MMSE)
Number of subjects: 457
Study: 32804388

Group type: EXPERIMENTAL
Intervention: Gum-elastic bougie (GEB)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Semirigid stylet
Number of subjects: 50
Study: 35256388

Group type: EXPERIMENTAL
Intervention: Small Change Approach (SCA)
Number of subjects: 320

Group type: COMPARATOR
Intervention: Monitoring Alone (MA)
Number of subjects: 320
Study: 33872709

Group type: EXPERIMENTAL
Intervention: Qigong exercise
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control (stretching exercise)
Number of subjects: 48
Study: 32739305

Group type: EXPERIMENTAL
Intervention: Deferred revascularization based on fractional flow reserve in ACS patients
Number of subjects: 8579

Group type: COMPARATOR
Intervention: Deferred revascularization based on fractional flow reserve in SAP patients
Number of subjects: 8579

Group type: EXPERIMENTAL
Intervention: Unplanned revascularization in ACS patients
Number of subjects: 8579

Group type: COMPARATOR
Intervention: Unplanned revascularization in SAP patients
Number of subjects: 8579

Group type: EXPERIMENTAL
Intervention: Treated patients (both ACS and SAP)
Number of subjects: 8579
Study: 35973188

Group type: EXPERIMENTAL
Intervention: Freshwater fish-based diet (F group)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Freshwater fish-based and red meat-based diets alternately (F/M group)
Number of subjects: 34
Study: 34370587

Group type: EXPERIMENTAL
Intervention: Itraconazole
Number of subjects: 76

Group type: EXPERIMENTAL
Intervention: Hydroxyitraconazole
Number of subjects: 76
Study: 36149164

Group type: COMPARATOR
Intervention: Conventional field EBRT 50 Gy with concurrent weekly chemotherapy followed by ICBT
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Extended field EBRT 50 Gy with concurrent weekly chemotherapy followed by ICBT
Number of subjects: 50
Study: 32839849

Group type: EXPERIMENTAL
Intervention: Iliac crest autograft
Number of subjects: 46

Group type: COMPARATOR
Intervention: Iliac crest allograft
Number of subjects: 46
Study: 35610014

Group type: EXPERIMENTAL
Intervention: Zhuling decoction
Number of subjects: 96

Group type: COMPARATOR
Intervention: Conventional treatment alone
Number of subjects: 96
Study: 33482853

Group type: EXPERIMENTAL
Intervention: Berberine (BBR)
Number of subjects: 118

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 118
Study: 33300853

Group type: EXPERIMENTAL
Intervention: Systemic rehydration (oral fluid consumption)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Local rehydration (nebulized isotonic saline)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Dehydration (exercise in heat or fluid restriction)
Number of subjects: 10
Study: 32325164

Group type: EXPERIMENTAL
Intervention: 5% dextrose water (D5W) and corticosteroid (triamcinolone acetonide, 10mg/mL) injection
Number of subjects: 36

Group type: COMPARATOR
Intervention: Corticosteroid (triamcinolone acetonide, 10mg/mL) injection
Number of subjects: 36
Study: 32007991

Group type: EXPERIMENTAL
Intervention: Global Postural Reeducation (GPR) method, implemented for 72 treatment sessions, 3 times a week for 24 weeks
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Global Postural Reeducation (GPR) method
Number of subjects: 90
Study: 34243836

Group type: EXPERIMENTAL
Intervention: TYRX Absorbable Antibacterial Envelope adjunctive to standard of care
Number of subjects: 3

Group type: COMPARATOR
Intervention: Standard of care infection prevention alone
Number of subjects: 3
Study: 33050401

Group type: EXPERIMENTAL
Intervention: Telephone-delivered dietary intervention
Number of subjects: 155

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 155
Study: 35815323

Group type: EXPERIMENTAL
Intervention: Intracervical injection of combination liposomal bupivacaine and bupivacaine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo (control group)
Number of subjects: 60
Study: 33539955

Group type: EXPERIMENTAL
Intervention: Gastroretentive tablets containing cilnidipine
Number of subjects: 0

Group type: COMPARATOR
Intervention: Reference tablets
Number of subjects: 0
Study: 32145522

Group type: EXPERIMENTAL
Intervention: Haptic
Number of subjects: 41

Group type: COMPARATOR
Intervention: Sensorimotor
Number of subjects: 41
Study: 35316101

Group type: EXPERIMENTAL
Intervention: Partial middle turbinate resection
Number of subjects: 49
Study: 33341816

Group type: EXPERIMENTAL
Intervention: Colorful Semantics (CS) protocol in augmentative communication (AC) intervention
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group AC intervention without CS protocol
Number of subjects: 40
Study: 32463519

Group type: EXPERIMENTAL
Intervention: Paravertebral nerve block of nerves T18, L1, and L2
Number of subjects: 12

Group type: COMPARATOR
Intervention: Local portal blocks of the three laparoscopic portals
Number of subjects: 12
Study: 34483276

Group type: EXPERIMENTAL
Intervention: Azithromycin (20 mg/kg height-based dosing) administered 4 times per year for 1 year
Number of subjects: 1255

Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 1255
Study: 34236905

Group type: EXPERIMENTAL
Intervention: LASIK
Number of subjects: 22

Group type: COMPARATOR
Intervention: SMILE
Number of subjects: 22
Study: 33728657

Group type: EXPERIMENTAL
Intervention: Dienogest
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: Combined Oral Contraceptive Pill (COCP)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 108
Study: 33989386

Group type: EXPERIMENTAL
Intervention: Long-read sequencing technology combined with RNA-seq for transcriptomic analysis
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Long-read sequencing technology combined with RNA-seq
Number of subjects: 0
Study: 32699126

Group type: EXPERIMENTAL
Intervention: Twelve-week Slimming World (SW) commercial group weight management programme, commencing anytime from 8 to 16 weeks postnatally.
Number of subjects: 98
Study: 35544137

Group type: EXPERIMENTAL
Intervention: Bayesian adaptive trial design
Number of subjects: 1151

Group type: COMPARATOR
Intervention: Frequentist adaptive trial design
Number of subjects: 1151
Study: 36265101

Group type: COMPARATOR
Intervention: Triple metronomic chemotherapy (TMC): oral methotrexate 9 mg/m2 once a week, celecoxib 200 mg twice daily, erlotinib 150 mg once daily
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: TMC with intravenous nivolumab (TMC-I): TMC plus nivolumab 20 mg flat dose once every 3 weeks
Number of subjects: 151

Group type: COMPARATOR
Intervention: TMC
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: TMC-I
Number of subjects: 151
Study: 34440949

Group type: EXPERIMENTAL
Intervention: Continuous Theta Burst Stimulation (cTBS) - 2400 pulses/day for 5 days
Number of subjects: 15

Group type: COMPARATOR
Intervention: Sham treatment
Number of subjects: 15
Study: 34928182

Group type: EXPERIMENTAL
Intervention: Intravenous lipid emulsion (ILE) - 100 ml of 20% ILE bolus followed by 100 ml of 20% ILE infusion over 6 hours
Number of subjects: 45

Group type: COMPARATOR
Intervention: Normal saline (control group)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Intravenous lipid emulsion (ILE)
Number of subjects: 45
Study: 34102144

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT) combined with standard care (4×4 minutes of treadmill HIIT at 85%-95% of peak heart rate)
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT) combined with standard care
Number of subjects: 70

Group type: COMPARATOR
Intervention: Standard care only
Number of subjects: 70
Study: 35218356

Group type: EXPERIMENTAL
Intervention: Second dose of measles vaccine (MV2) at 18 months of age
Number of subjects: 3164

Group type: COMPARATOR
Intervention: No vaccine (control group)
Number of subjects: 3164

Group type: EXPERIMENTAL
Intervention: Second dose of measles vaccine (MV2) after OPV campaigns
Number of subjects: 3164
Study: 34275209

Group type: EXPERIMENTAL
Intervention: Simvastatin 40 mg daily
Number of subjects: 73

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 73
Study: 32275359

Group type: EXPERIMENTAL
Intervention: Fire needling treatment (at Lianquan (CV 23), Fengchi (GB 20), Wangu (GB 12), Shuigou (GV 26), Neiguan (PC 6), and Zusanli (ST 36) without needle retaining every other day)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Swallowing function rehabilitation training (control group)
Number of subjects: 76
Study: 34732586

Group type: EXPERIMENTAL
Intervention: Positive-pressure extubation technique (application of pressure support mode at 15/10 cm H2O during cuff deflation and extubation)
Number of subjects: 725

Group type: COMPARATOR
Intervention: Traditional extubation technique (removing the endotracheal tube by applying continuous endotracheal suctioning during the entire procedure)
Number of subjects: 725
Study: 34154510

Group type: EXPERIMENTAL
Intervention: Statin therapy
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Statin group
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 32734378

Group type: EXPERIMENTAL
Intervention: Cathodal tDCS combined with visual feedback
Number of subjects: 90

Group type: COMPARATOR
Intervention: Visual feedback alone
Number of subjects: 90

Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 90

Group type: COMPARATOR
Intervention: Anodal tDCS
Number of subjects: 90
Study: 34349248

Group type: EXPERIMENTAL
Intervention: Lactococcus lactis subsp. cremoris YRC3780
Number of subjects: 27

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 27
Study: 32016519

Group type: EXPERIMENTAL
Intervention: Water with simethicone
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Water with simethicone plus NAC 600 mg
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Water with simethicone, NAC, sodium bicarbonate and peppermint
Number of subjects: 128

Group type: COMPARATOR
Intervention: Water (Control Group A)
Number of subjects: 128
Study: 34040762

Group type: EXPERIMENTAL
Intervention: 5 mg melatonin tablets
Number of subjects: 204

Group type: EXPERIMENTAL
Intervention: 10 mg melatonin tablets
Number of subjects: 204

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 204
Study: 35505174

Group type: EXPERIMENTAL
Intervention: 35 mg intravenous rhPro‐UK (n = 40)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: 50 mg intravenous rhPro‐UK (n = 39)
Number of subjects: 119

Group type: COMPARATOR
Intervention: 0.9 mg/kg recombinant tissue plasminogen activator (r‐tPA; n = 40)
Number of subjects: 119

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 119
Study: 34010810

Group type: EXPERIMENTAL
Intervention: Resistance training for empowerment (experimental group)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Active control group
Number of subjects: 24
Study: 36334720

Group type: EXPERIMENTAL
Intervention: Epinephrine 1 mg intranasal spray (neffy)
Number of subjects: 175

Group type: COMPARATOR
Intervention: Manual intramuscular epinephrine 0.3 mg injection
Number of subjects: 175

Group type: COMPARATOR
Intervention: Epinephrine 0.3 mg autoinjectors (Symjepi)
Number of subjects: 175

Group type: COMPARATOR
Intervention: Epinephrine 0.3 mg autoinjectors (EpiPen)
Number of subjects: 175
Study: 33998369

Group type: EXPERIMENTAL
Intervention: Simulated malingering group (n = 50)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Best-effort/control group (n = 50)
Number of subjects: 100
Study: 32147750

Group type: EXPERIMENTAL
Intervention: SPT-07A 10 mg
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: SPT-07A 20 mg
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: SPT-07A 40 mg
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36
Study: 33307959

Group type: EXPERIMENTAL
Intervention: Dopamine antagonist
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Dopamine agonist
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 17
Study: 32616246

Group type: EXPERIMENTAL
Intervention: Soybean oil (1.5%)
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Peanut oil (1.5%)
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Corn oil (1.5%)
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Olive oil (1.5%)
Number of subjects: 360
Study: 34146915

Group type: EXPERIMENTAL
Intervention: Monounsaturated fatty acids (MUFAs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Saturated fatty acids (SFAs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Polyunsaturated fatty acids (PUFAs)
Number of subjects: 0
Study: 33103929

Group type: EXPERIMENTAL
Intervention: Influencers with broad smiles
Number of subjects: 0

Group type: COMPARATOR
Intervention: Influencers with closed smiles
Number of subjects: 0
Study: 34332616

Group type: EXPERIMENTAL
Intervention: CBM‐IClin intervention (four sessions at home)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 0
Study: 35239511

Group type: EXPERIMENTAL
Intervention: Gut decontamination (GD) with oral vancomycin-polymyxin B from day -5 through neutrophil engraftment
Number of subjects: 20

Group type: COMPARATOR
Intervention: No gut decontamination (no-GD)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Gut decontamination (GD)
Number of subjects: 20
Study: 32978183

Group type: EXPERIMENTAL
Intervention: Intervention group receiving care accompanied by reinstruction and remotivation by dental assistants using the 'Oral Health Toolbox'.
Number of subjects: 618

Group type: COMPARATOR
Intervention: Control group receiving care as usual.
Number of subjects: 618

Group type: EXPERIMENTAL
Intervention: Intervention group.
Number of subjects: 618

Group type: COMPARATOR
Intervention: Control group.
Number of subjects: 618
Study: 33558263

Group type: EXPERIMENTAL
Intervention: Rectal indomethacin plus epinephrine (EI)
Number of subjects: 548

Group type: COMPARATOR
Intervention: Rectal indomethacin plus sterile water (WI)
Number of subjects: 548

Group type: EXPERIMENTAL
Intervention: Pancreatic duct guidewire insertion
Number of subjects: 548
Study: 32407060

Group type: EXPERIMENTAL
Intervention: Piezoelectric surgery
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional rotary burs
Number of subjects: 0
Study: 35777882

Group type: EXPERIMENTAL
Intervention: Individualised Computerised Cognitive Training (CCT)
Number of subjects: 200

Group type: EXPERIMENTAL
Intervention: Whole-food, plant-based diet
Number of subjects: 200

Group type: COMPARATOR
Intervention: Basic Computerised Cognitive Training (CCT)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Healthy diet following the current guidelines of the German Nutrition Society
Number of subjects: 200
Study: 33934456

Group type: EXPERIMENTAL
Intervention: Dasiglucagon (0.6 mg)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Reconstituted glucagon (GlucaGen)
Number of subjects: 42
Study: 32320844

Group type: EXPERIMENTAL
Intervention: Aliviado Dementia Care program
Number of subjects: 345

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 345
Study: 35946884

Group type: EXPERIMENTAL
Intervention: Standard physiotherapy + resistance training (TG)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard physiotherapy (CG)
Number of subjects: 30
Study: 34547165

Group type: EXPERIMENTAL
Intervention: Kinesio taping with manual therapy (KTMT)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Manual therapy (MT)
Number of subjects: 0
Study: 32030508

Group type: EXPERIMENTAL
Intervention: Saroglitazar 4 mg
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 33566629

Group type: EXPERIMENTAL
Intervention: NACD+PRP
Number of subjects: 80

Group type: COMPARATOR
Intervention: NACD+corticosteroids
Number of subjects: 80
Study: 32233001

Group type: EXPERIMENTAL
Intervention: Educational intervention (two-day intensive workshop combining reading materials)
Number of subjects: 37

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 37